Sage Therapeutics Inc (SAGE)

03:44 AM

Sage Therapeutics (NASDAQ:SAGE) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat

03:44 AM

Jul 25, 2025

Sage Therapeutics (SAGE) Expected to Announce Earnings on Wednesday - MarketBeat

Jul 25, 2025

Jul 25, 2025

Cwm LLC Acquires 58,410 Shares of Sage Therapeutics, Inc. (NASDAQ:SAGE) - MarketBeat

Jul 25, 2025

Jul 23, 2025

What drives Sage Therapeutics Inc. stock priceUnbelievable profit margins - Autocar Professional

Jul 23, 2025

Jul 23, 2025

What analysts say about Sage Therapeutics Inc. stockFree Investment Community - Autocar Professional

Jul 23, 2025

Jul 23, 2025

Sage Therapeutics Inc. Stock Analysis and ForecastMarket-beating returns - jammulinksnews.com

Jul 23, 2025

Jul 22, 2025

Is Sage Therapeutics Inc. a good long term investmentFree Daily Trading Room Entry - jammulinksnews.com

Jul 22, 2025

Jul 22, 2025

Layoff Tracker: GSK, Sail, BioNTech Cut Staff for Second Time This Year - BioSpace

Jul 22, 2025

Jul 20, 2025

Sage Therapeutics (NASDAQ:SAGE) Stock Price Crosses Above 50 Day Moving AverageHere's Why - MarketBeat

Jul 20, 2025

Jul 18, 2025

ALERT: Rowley Law PLLC Is Investigating Proposed Acquisition of Sage Therapeutics, Inc. - 富途牛牛

Jul 18, 2025

Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, - openPR.com

Jul 15, 2025

Jul 15, 2025

Status Epilepticus Pipeline 2025: Key Companies, MOA, ROA, and Clinical Trials Evaluation by DelveInsight | Marinus Pharmac, Pfizer, UCB Biopharma, Rafa Laboratories, Sage Therapeutics - The Globe and Mail

Jul 15, 2025

Jul 14, 2025

SAGE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Sage Therapeutics, Inc.SAGE - Business Wire

Jul 14, 2025

Jul 13, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jul 13, 2025

Jul 12, 2025

Sage Therapeutics (NASDAQ:SAGE) Downgraded to Hold Rating by Scotiabank - MarketBeat

Jul 12, 2025

Jul 11, 2025

SAGE Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Sage Therapeutics, Inc. is Fair to Shareholders - ACCESS Newswire

Jul 11, 2025

Jul 11, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Connect - ACCESS Newswire

Jul 11, 2025

Jul 10, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Average Rating of "Reduce" from Analysts - MarketBeat

Jul 10, 2025

Jul 10, 2025

Sage Therapeutics (NASDAQ:SAGE) Rating Lowered to “Hold” at Scotiabank - Defense World

Jul 10, 2025

Jul 09, 2025

Sage Therapeutics Announces Workforce Reductions Following Recent Acquisition Plans - geneonline.com

Jul 09, 2025

Jul 09, 2025

Postpartum Depression Pipeline 2025: Detailed Clinical Trials and FDA-Approved Therapies Review by DelveInsight | SAGE Therapeutics, Brii Biosciences Limited, Reunion Neuroscience, GH Research - Barchart.com

Jul 09, 2025

Jul 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Sage Therapeutics, Inc. (SAGE) And Encourages Shareholders to Reach Out - ACCESS Newswire

Jul 08, 2025

Jul 08, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates NVEE, SAGE, OLO on Behalf of Shareholders - Morningstar

Jul 08, 2025

Jul 08, 2025

Beyond The Numbers: 6 Analysts Discuss Sage Therapeutics Stock - Nasdaq

Jul 08, 2025

Jul 08, 2025

SAGE: Scotiabank Downgrades Sage Therapeutics with Price Target Adjustment | SAGE Stock News - GuruFocus

Jul 08, 2025

Jul 08, 2025

Scotiabank Downgrades SAGE Therapeutics to Sector Perform From Sector Outperform, Adjusts Price Target to $9.20 From $12 - MarketScreener

Jul 08, 2025

Jul 08, 2025

Wealth Enhancement Advisory Services LLC Takes $347,000 Position in Sage Therapeutics, Inc. (NASDAQ:SAGE) - Defense World

Jul 08, 2025

Jul 08, 2025

Scotiabank Downgrades Sage Therapeutics (SAGE) - MSN

Jul 08, 2025

Jul 07, 2025

Sage Therapeutics (NASDAQ:SAGE) Share Price Passes Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat

Jul 07, 2025

Jul 06, 2025

Sage Therapeutics' Q1 Earnings Miss Mark, Revenue Rise Y/Y - MSN

Jul 06, 2025

Jul 06, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sage Therapeutics, Inc. (SAGE) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Jul 06, 2025

Jul 06, 2025

Sage Therapeutics, Inc. (NASDAQ:SAGE) Receives Consensus Rating of “Hold” from Analysts - Defense World

Jul 06, 2025

Jul 04, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 04, 2025

Jul 03, 2025

$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: CARM, GNTY, TSBX, and SAGE - Eastern Progress

Jul 03, 2025

Jul 01, 2025

Sage Therapeutics, Inc. (SAGE) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jul 01, 2025

Jul 01, 2025

What Makes Sage Therapeutics (SAGE) a New Buy Stock - Yahoo Finance

Jul 01, 2025

Jun 30, 2025

Sage to lay off most staff amid Supernus buyout - BioPharma Dive

Jun 30, 2025

Jun 29, 2025

Levi & Korsinsky Reminds Sage Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – SAGE - ACCESS Newswire

Jun 29, 2025

Jun 27, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

Jun 27, 2025